These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 16038480)
1. Muscle and liver lactate metabolism in HAART-treated and naive HIV-infected patients: the MITOVIR study. Ghosn J; Guiguet M; Jardel C; Benyaou R; Zeller V; Simon A; Valantin MA; Amellal B; Assoumo L; Hogrel JY; Costagliola D; Katlama C; Lombès A Antivir Ther; 2005; 10(4):543-50. PubMed ID: 16038480 [TBL] [Abstract][Full Text] [Related]
2. Hyperlactataemia in HIV-infected patients: the role of NRTI-treatment. Vrouenraets SM; Treskes M; Regez RM; Troost N; Smulders YM; Weigel HM; Frissen PH; Brinkman K Antivir Ther; 2002 Dec; 7(4):239-44. PubMed ID: 12553477 [TBL] [Abstract][Full Text] [Related]
3. Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine. Walker UA; Bäuerle J; Laguno M; Murillas J; Mauss S; Schmutz G; Setzer B; Miquel R; Gatell JM; Mallolas J Hepatology; 2004 Feb; 39(2):311-7. PubMed ID: 14767983 [TBL] [Abstract][Full Text] [Related]
4. Kinetics of lactate metabolism after submaximal ergometric exercise in HIV-infected patients. Bauer AM; Sternfeld T; Horster S; Schunk M; Goebel FD; Bogner JR HIV Med; 2004 Sep; 5(5):371-6. PubMed ID: 15369513 [TBL] [Abstract][Full Text] [Related]
5. Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy. Haugaard SB; Andersen O; Pedersen SB; Dela F; Richelsen B; Nielsen JO; Madsbad S; Iversen J J Med Virol; 2005 Sep; 77(1):29-38. PubMed ID: 16032748 [TBL] [Abstract][Full Text] [Related]
6. Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naïve patients. Maagaard A; Holberg-Petersen M; Kvittingen EA; Sandvik L; Bruun JN HIV Med; 2006 Jan; 7(1):53-8. PubMed ID: 16313293 [TBL] [Abstract][Full Text] [Related]
7. Limitation of exercise capacity in nucleoside-treated HIV-infected patients with hyperlactataemia. Duong M; Dumas JP; Buisson M; Martha B; Piroth L; Grappin M; Waldner A; Chavanet P; Portier H HIV Med; 2007 Mar; 8(2):105-11. PubMed ID: 17352767 [TBL] [Abstract][Full Text] [Related]
8. A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa. Bolhaar MG; Karstaedt AS Clin Infect Dis; 2007 Jul; 45(2):254-60. PubMed ID: 17578788 [TBL] [Abstract][Full Text] [Related]
9. [13C]Methionine breath test: a novel method to detect antiretroviral drug-related mitochondrial toxicity. Milazzo L; Piazza M; Sangaletti O; Gatti N; Cappelletti A; Adorni F; Antinori S; Galli M; Moroni M; Riva A J Antimicrob Chemother; 2005 Jan; 55(1):84-9. PubMed ID: 15590719 [TBL] [Abstract][Full Text] [Related]
10. In vivo effects of highly active antiretroviral therapies containing the protease inhibitor nelfinavir on mitochondrially driven apoptosis. Miró O; Villarroya J; Garrabou G; López S; Rodríguez de la Concepción M; Pedrol E; Martínez E; Giralt M; Gatell JM; Cardellach F; Casademont J; Villarroya F Antivir Ther; 2005; 10(8):945-51. PubMed ID: 16430200 [TBL] [Abstract][Full Text] [Related]
11. Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone. Jones R; Sawleshwarkar S; Michailidis C; Jackson A; Mandalia S; Stebbing J; Bower M; Nelson M; Gazzard BG; Moyle GJ HIV Med; 2005 Nov; 6(6):396-402. PubMed ID: 16268821 [TBL] [Abstract][Full Text] [Related]
12. Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment. Maagaard A; Holberg-Petersen M; Løvgården G; Holm M; Pettersen FO; Kvale D J Infect Dis; 2008 Nov; 198(10):1474-81. PubMed ID: 18851688 [TBL] [Abstract][Full Text] [Related]
13. Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients. Maagaard A; Holberg-Petersen M; Kollberg G; Oldfors A; Sandvik L; Bruun JN Antivir Ther; 2006; 11(5):601-8. PubMed ID: 16964828 [TBL] [Abstract][Full Text] [Related]
14. Skeletal muscle mitochondrial DNA content and aerobic metabolism in patients with antiretroviral therapy-associated lipoatrophy. Sutinen J; Laaksonen MS; Walker UA; Setzer B; Kemppainen J; Nuutila P; Yki-Järvinen H J Antimicrob Chemother; 2010 Jul; 65(7):1497-504. PubMed ID: 20444746 [TBL] [Abstract][Full Text] [Related]
15. Successful simplification of protease inhibitor-based HAART with triple nucleoside regimens in children vertically infected with HIV. Palma P; Romiti ML; Cancrini C; Pensieroso S; Montesano C; Santucci MB; Bernardi S; Martino AM; Rossi P; Castelli-Gattinara G AIDS; 2007 Nov; 21(18):2465-72. PubMed ID: 18025883 [TBL] [Abstract][Full Text] [Related]